Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Octavi Bassegoda

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
JHEP Reports : Innovation in Hepatology|September 5, 2022
Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosisJesús Rivera-Esteban, Ramiro Manzano-Nuñez, Teresa Broquetas, et al.
Journal of Hepatology|October 17, 2020
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosisJosé Ferrusquía-Acosta, Octavi Bassegoda, Laura Turco, et al.
Blood Purification|January 19, 2025
Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Case SeriesNatalia Jiménez-Esquivel, Gastón Piñeiro, Adrià Carpio, et al.
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
Journal of Hepatology|January 19, 2020
Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomesOctavi Bassegoda, Patricia Huelin, Xavier Ariza, et al.
Hepatology Communications|September 8, 2022
High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort studyOctavi Bassegoda, Jesús Rivera-Esteban, Isabel Serra, et al.
Hepatology Communications|May 10, 2022
Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcomeLaura Napoleone, Cristina Solé, Adrià Juanola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2021
Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndromeCristina Solé, Ann T Ma, Elsa Solà, et al.
Journal of Hepatology|September 16, 2021
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosisAdrià Juanola, Isabel Graupera, Chiara Elia, et al.
Hepatology (Baltimore, Md.)|February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective StudyPatricia Huelin, Elsa Solà, Chiara Elia, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
JHEP Reports : Innovation in Hepatology|September 5, 2022
Impact of the COVID-19 pandemic on the care and outcomes of people with NAFLD-related cirrhosisJesús Rivera-Esteban, Ramiro Manzano-Nuñez, Teresa Broquetas, et al.
Journal of Hepatology|October 17, 2020
Agreement between wedged hepatic venous pressure and portal pressure in non-alcoholic steatohepatitis-related cirrhosisJosé Ferrusquía-Acosta, Octavi Bassegoda, Laura Turco, et al.
Blood Purification|January 19, 2025
Bilirubin Removal with Therapeutic Plasma Exchange or Molecular Adsorbent Recirculating System as Treatment for Cholemic Nephropathy in Patients with Cirrhosis and Acute-on-Chronic Liver Failure: A Case SeriesNatalia Jiménez-Esquivel, Gastón Piñeiro, Adrià Carpio, et al.
Journal of Hepatology|September 8, 2025
The barriers to uptake of artificial intelligence in hepatology and how to overcome themJan Clusmann, Maria Balaguer-Montero, Octavi Bassegoda, et al.
Journal of Hepatology|January 19, 2020
Development of chronic kidney disease after acute kidney injury in patients with cirrhosis is common and impairs clinical outcomesOctavi Bassegoda, Patricia Huelin, Xavier Ariza, et al.
Hepatology Communications|September 8, 2022
High frequency of acute decompensation and cancer in patients with compensated cirrhosis due to nonalcoholic fatty liver disease: A retrospective cohort studyOctavi Bassegoda, Jesús Rivera-Esteban, Isabel Serra, et al.
Hepatology Communications|May 10, 2022
Patterns of kidney dysfunction in acute-on-chronic liver failure: Relationship with kidney and patients' outcomeLaura Napoleone, Cristina Solé, Adrià Juanola, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 27, 2021
Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndromeCristina Solé, Ann T Ma, Elsa Solà, et al.
Journal of Hepatology|September 16, 2021
Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosisAdrià Juanola, Isabel Graupera, Chiara Elia, et al.
Hepatology (Baltimore, Md.)|February 28, 2019
Neutrophil Gelatinase-Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective StudyPatricia Huelin, Elsa Solà, Chiara Elia, et al.
Pageof 3